The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Susceptibility to innate immune activation in genetically mediated myocarditis
Open accessAbstract
Myocarditis is clinically characterized by chest pain, arrhythmias, and heart failure, and treatment is often supportive. Mutations in DSP , a gene encoding the desmosomal protein desmoplakin, have been increasingly implicated in myocarditis. To model DSP -associated myocarditis and assess the role of innate immunity, we generated engineered heart tissues (EHTs) using human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) from patients with heterozygous DSP truncating variants ( DSP tvs) and a gene-edited homozygous deletion cell line ( DSP –/– ). At baseline, DSP –/– EHTs displayed a transcriptomic signature of innate immune activation, which was mirrored by cytokine release. Importantly, DSP –/– EHTs were hypersensitive to Toll-like receptor (TLR) stimulation, demonstrating more contractile dysfunction compared with isogenic controls. Relative to DSP –/– EHTs, heterozygous DSP tv EHTs had less functional impairment. DSP tv EHTs displayed heightened sensitivity to TLR stimulation, and when subjected to strain, DSP tv EHTs developed functional deficits, indicating reduced contractile reserve compared with healthy controls. Colchicine or NF-κB inhibitors improved strain-induced force deficits in DSP tv EHTs. Genomic correction of DSP p.R1951X using adenine base editing reduced inflammatory biomarker release from EHTs. Thus, EHTs replicate electrical and contractile phenotypes seen in human myocarditis, implicating cytokine release as a key part of the myogenic susceptibility to inflammation. The heightened innate immune activation and sensitivity are targets for clinical intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of monumental importance, genetic correction of DSP p.R1951X was accompanied by a substantial reduction in NFκB mRNA expression, further suggesting that the mere presence of a desmosomal gene variant drives myocardial inflammation rather than being a consequence of infiltrating immune cells.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At baseline, DSP−/− EHTs exhibit a transcriptomic signature of innate immune activation, mirrored by elevated concentrations of multiple cytokines, including IL-1β, IL-6, IL-8, IFN-γ, IL-17, and IL-23, which were detected in the EHT cell culture media; thus, they are of cardiomyocyte origin rather than from immune cells [70].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DSP-linked ACM is strongly associated with a myocardial fibro-inflammatory phenotype and a higher frequency of episodic “hot phases,” typically manifesting in the left ventricle and frequently observed via LGE-MRI [52,70].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anti-inflammatory strategies, including colchicine, a broad anti-inflammatory agent, or NFκB inhibitors, effectively rescue these force deficits.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, heterozygous DSP-tv EHTs exhibited only minimal baseline contractile deficits, though they exhibited elevated innate immune activation relative to healthy controls, reflected by increased IL-1β secretion into cell culture media upon Toll-like receptor (TLR) stimulation via exogenous application of HMGB1.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Easy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390 · cited 1×
“After 10 days, colonies were isolated and then screened by Sanger sequencing and TIDE analysis (67).”
MethodCRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
Concordet, J.-P., & Haeussler, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky354 · Cited by 2,327
Chemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606
Self-citationCardioimmunology: the immune system in cardiac homeostasis and disease
Swirski, F. K., & Nahrendorf, M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0065-8 · Cited by 849
Arrhythmogenic Right Ventricular Cardiomyopathy
Corrado, D., Link, M. S., & Calkins, H. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509267 · Cited by 736
Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing
Atcha, H., Jairaman, A., Holt, J. R., Meli, V. S., Nagalla, R. R., Veerasubramanian, P. K., Brumm, K. T., Lim, H. E., Othy, S., Cahalan, M. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23482-5 · Cited by 644
Giacomelli, E., Meraviglia, V., Campostrini, G., Cochrane, A., Cao, X., van Helden, R. W. J., Krotenberg Garcia, A., Mircea, M., Kostidis, S., Davis, R. P., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.05.004 · Cited by 622
EditR: A Method to Quantify Base Editing from Sanger Sequencing
Kluesner, M. G., Nedveck, D. A., Lahr, W. S., Garbe, J. R., Abrahante, J. E., Webber, B. R., & Moriarity, B. S. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0014 · Cited by 565
Cited by
Advances in the study and treatment of genetic cardiomyopathies
Parikh, V. N., Day, S. M., Lakdawala, N. K., Adler, E., Olivotto, I., Seidman, C. E., & Ho, C. Y. (2025) · Cell · doi:10.1016/j.cell.2025.01.011 · Cited by 51
Simultaneous electromechanical monitoring in engineered heart tissues using a mesoscale framework
Fullenkamp, D. E., Maeng, W., Oh, S., Luan, H., Kim, K. S., Chychula, I. A., Kim, J., Yoo, J., Holgren, C. W., Demonbreun, A. R., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado7089 · Cited by 43
Self-citationGasperetti, A., Muller, S. A., Peretto, G., Asatryan, B., Protonotarios, A., Laredo, M., Tarlet, P.-Y., Syrris, P., Carrick, R. T., Murray, B., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.073919 · Cited by 36
Desmoplakin Cardiomyopathy: Role of Inflammation and Potential Role of Disease-Modifying Therapies
Gasperetti, A., Carrick, R. T., Muller, S. A., Murray, B. A., Adamo, L., Bauce, B., McNally, E. M., & Helms, A. S. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02183-7 · Cited by 13
Self-citationMaihemuti, N., Shi, Y., Zhang, K., Jiang, X., Chu, J., Xu, Y., Xu, Z., & Wang, K. (2025) · MedComm · doi:10.1002/mco2.70308 · Cited by 12
Metadata
- Authors
- Selgrade, D. F., Fullenkamp, D. E., Chychula, I. A., Li, B., Dellefave-Castillo, L., Dubash, A. D., Ohiri, J., Monroe, T. O., Blancard, M., Tomar, G., Holgren, C., Burridge, P. W., George, A. L., Demonbreun, A. R., Puckelwartz, M. J., George, S. A., Efimov, I. R., Green, K. J., & McNally, E. M.
- Affiliations
- Center for Genetic Medicine and
- Northwestern University (US)
- Furman University (US)
- Department of Pharmacology,
- Corresponding author
- McNally, Elizabeth M.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2024-05-16
- Volume
- 134
- Issue
- 13
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC11213508
- OpenAlex
- W4398143267
- Cited by
- 30
- References
- 72
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 2
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- NIH (NIH HL128075 (EMM),NIH HL167813,NIH HL162454 (DFS),NIH HL163392 (DEF),NIH AR43380 (KJG),NIH HL134633 (DFS),Leducq TransAtlantic Foundation (DEF,EMM),International Institute for Nanotechnology Northwestern University (DFS),Chicago Biomedical Consortium PDR)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- desmoplakin, desmosomal proteins, innate immune activation, engineered heart tissue, hiPSC-derived cardiomyocytes, cytokine production, contractile dysfunction, NF-κB inhibition, colchicine, adenine base editing, gene correction, truncating mutations
- MeSH terms
- Female, Humans, Immunity, Innate, Male, Myocarditis, Genetic Predisposition to Disease, Myocytes, Cardiac, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Susceptibility to innate immune activation in genetically mediated myocarditis. https://app.cochat.ai/papers/10.1172/jci180254
- The paper
- Selgrade, D. F., Fullenkamp, D. E., Chychula, I. A., Li, B., Dellefave-Castillo, L., Dubash, A. D., Ohiri, J., Monroe, T. O., Blancard, M., Tomar, G., Holgren, C., Burridge, P. W., George, A. L., Demonbreun, A. R., Puckelwartz, M. J., George, S. A., Efimov, I. R., Green, K. J., & McNally, E. M. (2024). Susceptibility to innate immune activation in genetically mediated myocarditis. Journal of Clinical Investigation. https://doi.org/10.1172/jci180254
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.